Keyword: Georgia State University
Human-generated antibodies have provided new clues that could boost the development of a broadly protective antiviral drug and universal flu vaccine.
The past week’s biotech news included insight into how ApoE4 raises Alzheimer’s risk and a peptide vaccine for broad flu protection.
Georgia State researchers targeted a different part of the flu virus than the traditional seasonal vaccine does.
A team led by Washington University in St. Louis has unraveled the structure of a protein that allows RSV to elude the immune system.
GeoVax has partnered with Georgia State University to try to pursue an elusive goal—the development of an effective therapeutic vaccine for hepatitis B virus (HBV) infections.
Georgia State University researchers have designed a protein which they say can efficiently target an important cell surface receptor implicated in many diseases.